Our results showed no significant association between RAD52 expression and MMR protein expression in rectal cancer tissues, which suggests that the prognostic implications of high RAD52 levels may operate independently of the MMR machinery in rectal cancer. The gene discussed is MRC1; the disease is rectal cancer.